CELIAC DISEASE CD - PowerPoint PPT Presentation

1 / 37
About This Presentation
Title:

CELIAC DISEASE CD

Description:

CELIAC DISEASE (CD) ... Symptoms improve within days to weeks. Pathological changes take months or longer. ... working group on celiac disease of the European ... – PowerPoint PPT presentation

Number of Views:62
Avg rating:3.0/5.0
Slides: 38
Provided by: bakd
Category:

less

Transcript and Presenter's Notes

Title: CELIAC DISEASE CD


1
????? ???????CELIAC DISEASE (CD)
  • DR.NIZAR ALHARBAT
  • CONSALTANTE OF PEDIATRIC
  • ARAB BORD

2
????? ???????CELIAC DISEASE (CD)
  • ?????? ????? ???? ????? ????? ?? ?????? ???????
    ???????? ????? ????????? ??????? ?? ?????? ?????
    ??? ????? ??????? ???????.
  • ???? ??? ???????? ?? ?????? ??? ???? ???? ??
    ????????.

3
????? ?????? ???? ????
4
????? ??????? ???? ????? ????
  • ???? ??? CD ????? ????? ??????? ?????? ?? ???
  • ????????? ???????
  • ????? ?????? ???? HLA
  • DQ2 90
  • DQ8 8
  • ????? ??? ?????? ???? HLA
  • 5q31-33 - 2q33
  • ?????? ??????
  • ????????
  • ??????? ??????? ??????
  • ??????? ?????????? ???????? Tissue
    Transglutaminase tTG

5
????? ????? ??????? Celiac Disease (CD)
6
?????? ????????? ??? CD ???? ??? tTG
7
  • Celiac Disease is a genetically complex,
    multifactorial immune-mediated disease.
  • Gluten-derived peptides in susceptible
    individuals cause T-cell activation in the
    intestinal mucosa, which is followed by cytokine
    production and mucosal intestinal damage.

8
????? ????? ???????
9
????? ????? ???????
  • ???? ?????? Atypical
  • ?? ??? ???? ???? ????? ????????? ???? ?? ?? ????
    ????? ???? ??? ??? ????????.
  • ?????? ?? ???????? Silent/ Asymptomatic
  • ??? ?????? ???? ???? ?? ???? ?????? ????? ?????
    ????? ????? ??? ??????.
  • ????????? Potential
  • ???? ????? ??? ??????? ????? ??? ????? ????????.
  • ?????? Latent
  • ?? ???? ???? ??????? ???? ????? ????? ???? ??????
    ?? ???????? ?????.

10
??? ??? ?????? ??? CD
11
??? ???? ??? CD
12
?????? ????? ??? CDThe Present ( ESPGHAN - 1990 )
  • ??? ????? ???????? ?????? ??????? ?? ??? CD
  • ???? ????? ???????
  • ???? ?????? ????? ??????? ?? ??? CD
  • ??????? ?????? ?????? ????? ?????? ??????? ??
    ????????
  • ????? ???? ?? ?????
  • ??????? ??????? ???????? ?????? ???????? ??? CD

????? ????
13
(No Transcript)
14
.Wyllie,Hyams,Pediatric gastrointestinal disease,
Saunders, second edition 1999 .

??????? ???????
??????? ??????
??? ?????
15
??????? ???????
???? ???
???? ???????
???? ?????
??? ?????
?? ???? ??? ?????
16
??????? ?????
???? ???? ????? ???????
?????? ???? ?????
?? ???? ??? ?????
????? ????
???? ?????
???? ?????
?????? ??????
17
?????? ??????????
??? ??????? ?????????? ?? ??? ?? ????? ?????
???????? ??? ???? ?? ??????? ???????? ????? ?
??????? ?? ??????? 40 ? ?????? 60
18
?????? ??????? ??????? ???????
??? ?????? ??????? ??????? ??????? ?? ??? ??
??????? ?? ?? ?? ???? ?? ??????? ????????
?????? ? ?? ???? ??? ?????? ???? ?? ????? ?????
.
19
??? ?????? ?? ????? ??????
??? ??????? ??? ?????? ?? ????? ?????? ?? ??? ??
????? ?????.
20
?????? ??????? ?????? ????? ???????
Patients older than 2 years IgG IgA

21
?????? ??????? ??? CD
  • AGA IgG
  • ????? ??????? ?????
  • ?? ???? ??? ???? ???????? ???? ?????.
  • ?? ??????? ???? ?????????.
  • EMA IgA
  • ???? ??????? ??? ????
  • ?????? ?????? ??? ???????lt2 ???.
  • ??????? ????????
  • ???? ?????? ?????? ?? ????? ???????.
  • tTG IgGA
  • ????? ?????.
  • ????? ????? ?????? ??????? ???????
  • ?????? ????? (98.5).
  • ????? ?????? (98).
  • ?????? ??? ?????.

22
???????? ???????? ??? ???? ??? CD
Nelsen DA. Am Fam Physician 2002 662259-2266
23
??????? ??????
  • ???????? ????????? ???????? ?? ??????? ???
    ??????? ???
  • ????? ?? ??? ???????.
  • ???? ??? ???????? .
  • ??? ??????? ??? ????? ? ??? ????? ??? ???????
    .
  • ?? ????? ??????? ????? ???? ????? ?????? ????
    ????????
  • ( 4 6 ????? ) ??? ????? ?? ????? ???????
    ?????? ??? ???? ?????? ???? ???? ?????? ?? ??????
    ?? ????? ??????? ???? ?? ???? ?????? .

24
????? ??????
  • 1- ??? ??????? ??????? ???????? ?? ??? ???? ??
    ??? ????? ???? ???? ???????? ( ?????? ????? ) .
  • 2- ??? ???? ????? ??????? ( ???????? ???????
    ??????? ? ????? ?????? ) .
  • 3- ????? ????? ??????? ?????? ( ????? ??????? ?
    ??????? ) .
  • ?? ???? ?????? ???? ??? ????? ??????? ??????? ???
    ???? ??????? ??? ????????? ???? ????? ???
    ??????????? ???? ??????? TEL ? ???? ??????? ? ???
    ?????? ????? ?? ?????? ????? ????? ????? ???????
    ? ???? ??? ??? ??????? ??????? ?? ????? ??????
    ?????? ???? ??????? ??????? .
  • ???? ??? ??? ?????? ?????? ?? ???? ???? ???????
    ??????? ?????? ??????? ??? ???????? ???????
    ????????? ???? ????? ?? TEL ? ???????? ???????
    ??????? ??? ???? ??? ??????? ??????? ???? ???????
    ????? .

25
Marsh stage 1
Intraepithelial lymphocytosis (infiltrative
lesion, intraepithelial lymphocytes gt40 per 100
enterocytes)
Marsh stage 2
Lymphocytic enteritis with crypt hyperplasia
(hyperplastic lesion, villous abnormality
epithelial lymphocytosis)
26
Marsh stage 3
Marsh IIIA, partial villous atrophy.
Marsh IIIB, subtotal villous atrophy
Marsh IIIC, total villous atrophy.
27
  • ? ??? ??? ?????? ??????? ?? ??? ???????? ????? ??
    ???? ???????? ????? ?????? ?????? ?? ???????
    ????? ????? ??????? ? ???? ?????? ??????? ????? ?
    ???? ?? ????? ?????? ?????? ?????? ??????????
    ?????? ????? ??????? ??? ???? ??? ?? ???
    ????????? ??????? ????? ????? ? ???? ?????
    ???????? ??????? .
  • ???? ???? ??? ?? ?????? ?????? ?????? ????? ????
    ?????? ???????????? ?????? ??????? ??????????
    TTG ???????? ?? ???? ??????? ? ????? ??????? ?
    ?????? ??? ???? ??????? ? ???????? ??????? ??
    ??????? .
  • ? ?????? ??? ?? ?? ???????? ?????? ???????
    ??????? ??? ????? ???? ?? HLA ??? ????? ??? HLA
    ???? ?? ????? ???? ?????? ????? ????? ???????
    ?????? ??????? ??? ???? ???????? ??? ?? ???
    ?????? ????? ???? ??????? ?????? .
  • ????? HLA ?? ?????? ?? ??????? ?????? ?????
    ??????? ???? ???? ? ??? ????? ??? ???? .

28
  • ???? ?? ?????? ???? ?? ???? ?????? ??????
    ??????? ????? ??????? ? ? ???? ?? ???? ??????
    ?????? ?? ?????? ???????? ? ?? ???? ?? ??? ????
    ???? ???? ????? ??? ????? ?? ?????????? ???????
    ???????? .

29
Avoid for life
??????
  • ?????? ???????? ???? ???????? ?? ????? ? ?????? ?
    ?????? ? ?? ??????? ??????? ??? ????? .
  • ???????? ???? ??????? ????? ??? ??? ??????? ?
    ???????? ???? ???????. ? ?? ???? ????? ?????? ??
    ?? ??? ?? ??????? .

30
Medical Care
  • In the early phase of treatment, most patients
    may be lactose intolerant because of the
    reduction of available absorptive area.
  • Thus, a lactose-free (not milk-free) diet can be
    used, but only for the first few weeks because
    this condition is transient.
  • In some patients who present with obvious
    malabsorption, specific nutritional deficiencies
    must be sought and, if present, treated
    adequately with supplements. These most commonly
    include Fe, folate, and vitamin B-12.
  • It now appears that oats are safe, but long-term
    studies still are lacking

31
Treatment and Prognosis
  • Therapy of choice is lifelong gluten-free diet.
  • Major lifestyle change as common foods have to be
    substituted / avoided compromising taste.
  • Symptoms improve within days to weeks.
  • Pathological changes take months or longer.
  • Foods may be added back in small amounts
    (trial)!!!????????
  • Most common cause of failed therapy is dietary
    non-compliance (dietary education is necessary)

32
Treatment and Prognosis
  • Those not responding to diet are termed
    refractory sprue may respond to
  • Corticosteroids
  • Cyclosporine and azathioprine (not proven.)
  • Many develop secondary lactase deficiency
  • Avoid milk products until stable.
  • Replace vitamin and electrolyte deficiencies.
  • Prognosis is excellent for those who respond to a
    gluten-free diet (majority).

33
(No Transcript)
34
CD and Malignancy
UpToDate, 2006
35
FUTURE TREATMENT ????
  • Genetically engineered grains.
  • Enzymatic digestion of toxic gliadin peptides.
  • Inhibition of the zonulin pathway.
  • Blocking TTG enzymatic activity.
  • Blocking of gliadin peptide binding on HLA DQ2/8
    on APC.
  • Inhibition of antigen presentation by APC to T
    lymphocytes.
  • Inhibition of cytokine production and/or
    function.
  • Inhibition of activation of T killer lymphocytes.

36
RECOVERY
  • Dietary compliance can be the most difficult
    aspect of treatment.
  • BUT
    REWARDING.
  • The recovery in children seemed to progress
    faster and more completely than in adults.
  • Considered regression of mucosal abnormalities,
    with normalization of villi to Marsh 0, I, or II,
    as histological remission and, thus, the end
    point of the follow-up study.
  • The working group on celiac disease of the
    European Society for Paediatric Gastroenterology
    and Nutrition does not specifically define
    histological remission.

37
?????
Write a Comment
User Comments (0)
About PowerShow.com